Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-11

Clinical Trial Update: An Endometrial Cancer Chemoprevention Study of Metformin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating metformin for endometrial cancer chemoprevention has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gynecology | Phase 3 | Status: COMPLETED | Results posted: 2025-06-11